CSI Market
Sign In | Register

Aratana Therapeutics (PETX) Annual Balance Sheets

Annual · GAAP · USD millions
Access PETX quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Aratana Therapeutics finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2018)
(Dec 31 2017) (Dec 31 2016) (Dec 31 2015) (Dec 31 2014)
Assets
Cash & cash equivalent41.43
Short-term Investments, Total1.24
Cash & Short-term Investments42.00
Accounts receivable2.20
Inventories11.43
Derivatives, Collateral, Regulatory, Deferred0.00
Deferred Tax Assets, Net of Valuation Allowance, Current0.00
Prepaid Expense And Other Assets Current1.83
Total Current Assets58.13
Equipment/Property/Plant Net0.69
Goodwill net40.85
Intangible Assets6.10
Long-term investments0.35
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.32
Total Assets106.44
Liabilities
Accounts Payable, Current AC0.91
Accrued Liabilities, Current AC0.00
Loans Payable, Current NO0.00
Other Liabilities, Current0.00
Deferred Tax Liabilities, Net, Current LI0.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities5.56
Long-term debt0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net, Noncurrent LI0.00
Other liabilities, Noncurrent0.06
Accrued Liabilities And Other Liabilities Current4.65
Contract With Customer Liability Current-
Total Liabilities5.61
Stockholders' Equity
Development Stage Enterprise Deficit Accumulated During Development Stage-
Common Stock Value0.05
Treasury Stock Value-1.18
Additional Paid In Capital Common Stock350.75
Retained Earnings / Accumulated Deficit-241.24
Accumulated Other Comprehensive Income0.00
Other Equity-7.56
Common Stockholder's Equity100.82
Total Stockholder's Equity100.82
Liabilities & Stockholder's Equity106.44
4 historic quarters locked

Sign in to unlock the full Aratana Therapeutics balance sheet history.

Sign In Create Free Account

About PETX Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License